Literature DB >> 18521340

The relation between histological, tumor-biological and clinical parameters in deep and superficial leiomyosarcoma and leiomyoma.

Justin Pijpe1, Gerben H Torn Broers, Boudewijn E Ch Plaat, M Hundeiker, F Otto, Mirjam F Mastik, Harald J Hoekstra, Winette T A van der Graaf, Eva van Den Berg, Willemina M Molenaar.   

Abstract

PURPOSE: Leiomyosarcomas (LMS) of deep and superficial tissues were examined to identify prognostic markers explaining their different biological behaviour and to define differences between cutaneous and subcutaneous LMS. LMS and leiomyomas (LM) of the skin were compared to and consistent differences that could aid in the (sometimes difficult) diagnosis. PATIENTS: Material was obtained from 27 patients with a deep LMS, 14 with a superficial LMS, and 21 with a LM.
METHODS: Proliferation markers (mitotic and Ki-67 indices), DNA ploidy, size, grade, and the amount of apoptosis were studied. Statistical analysis was performed and survival curves were constructed by the Kaplan-Meier method and compared by the log-rank test.
RESULTS: Superficial LMS were smaller than deep LMS (p < 0.05), and the overall survival of patients with a superficial LMS was better than with a deep LMS (p < 0.05).Within the group of superficial LMS only entirely subcutaneous, and not cutaneous tumors metastasized.No differences were found in the other examined parameters. Proliferation and apoptotic indices were significantly higher in superficial LMS compared to superficial LM. DISCUSSION: The difference in clinical outcome between patients with a superficial and deep LMS, seems to be related to site and size.The metastatic potential of subcutaneous LMS, however, seems to be related to location alone and not to size.The amount of apoptosis and proliferation can be used as additional criteria in the differentiation between superficial LMS and LM.

Entities:  

Year:  2002        PMID: 18521340      PMCID: PMC2395483          DOI: 10.1080/1357714021000065404

Source DB:  PubMed          Journal:  Sarcoma        ISSN: 1357-714X


  21 in total

1.  Autoclave heating: an alternative method for microwaving?

Authors:  A Emanuels; H Hollema; J Koudstaal
Journal:  Eur J Morphol       Date:  1994-08

Review 2.  Tumors with smooth muscle differentiation.

Authors:  J M Spencer; R A Amonette
Journal:  Dermatol Surg       Date:  1996-09       Impact factor: 3.398

3.  Intradermal and subcutaneous leiomyosarcoma: a clinicopathological and immunohistochemical study of 41 cases.

Authors:  M L Jensen; O M Jensen; W Michalski; O S Nielsen; J Keller
Journal:  J Cutan Pathol       Date:  1996-10       Impact factor: 1.587

4.  Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content.

Authors:  P Gustafson; H Willén; B Baldetorp; M Fernö; M Akerman; A Rydholm
Journal:  Cancer       Date:  1992-07-01       Impact factor: 6.860

5.  Cutaneous and subcutaneous leiomyosarcoma. A clinicopathologic study of 47 patients.

Authors:  I Dahl; L Angervall
Journal:  Pathol Eur       Date:  1974

6.  Leiomyosarcoma of the skin and subcutaneous tissue.

Authors:  J P Fields; E B Helwig
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

7.  A consecutive 7-year series of 1331 benign soft tissue tumours. Clinicopathologic data. Comparison with sarcomas.

Authors:  O Myhre-Jensen
Journal:  Acta Orthop Scand       Date:  1981-06

8.  Prognostic significance of Ki-67 reactivity in soft tissue sarcomas.

Authors:  T Ueda; K Aozasa; M Tsujimoto; M Ohsawa; A Uchida; Y Aoki; K Ono; K Matsumoto
Journal:  Cancer       Date:  1989-04-15       Impact factor: 6.860

9.  Reproducibility of a histopathologic grading system for adult soft tissue sarcoma.

Authors:  J M Coindre; M Trojani; G Contesso; M David; J Rouesse; N B Bui; A Bodaert; I De Mascarel; A De Mascarel; J F Goussot
Journal:  Cancer       Date:  1986-07-15       Impact factor: 6.860

10.  DNA ploidy pattern and cell cycle stage of tumor cells in soft-tissue sarcomas: clinical implications.

Authors:  S Kuratsu; Y Tomita; A Myoui; A Uchida; K Ono; K Aozasa
Journal:  Oncology       Date:  1995 Sep-Oct       Impact factor: 2.935

View more
  6 in total

1.  Cutaneous leiomyosarcoma: treatment and outcomes with a standardized margin of resection.

Authors:  Jeremiah L Deneve; Jane L Messina; Marilyn M Bui; Suroosh S Marzban; G Douglas Letson; David Cheong; Ricardo J Gonzalez; Vernon K Sondak; Jonathan S Zager
Journal:  Cancer Control       Date:  2013-10       Impact factor: 3.302

2.  Somatic Leiomyosarcoma of the Soft Tissues: A Single-Institutional Analysis of Factors Predictive of Survival in 164 Patients.

Authors:  Kamran Harati; Adrien Daigeler; Kim Lange; Hiltrud Niggemann; Ingo Stricker; Hans-Ulrich Steinau; Marcus Lehnhardt; Ole Goertz
Journal:  World J Surg       Date:  2017-06       Impact factor: 3.352

3.  Predictors of survival and recurrence in primary leiomyosarcoma.

Authors:  Rebecca A Gladdy; Li-Xuan Qin; Nicole Moraco; Narasimhan P Agaram; Murray F Brennan; Samuel Singer
Journal:  Ann Surg Oncol       Date:  2013-01-25       Impact factor: 5.344

4.  Superficial soft tissue sarcomas of the extremities and trunk.

Authors:  Anja Lachenmayer; Qin Yang; Claus F Eisenberger; Edwin Boelke; Christopher Poremba; Antje Heinecke; Christian Ohmann; Wolfram Trudo Knoefel; Matthias Peiper
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

5.  A Case of Multiple Cutaneous Piloleiomyomas on the Neck.

Authors:  Yoon Jin Lee; Jin Ho Bae; Kyu Uang Whang; Moon Kyun Cho
Journal:  Ann Dermatol       Date:  2017-12-26       Impact factor: 1.444

6.  Hereditary Leiomyomatosis and Renal Cell Cancer.

Authors:  Anders Würgler Hansen; Zahràa Chayed; Kristine Pallesen; Ileana Codruta Vasilescu; Anette Bygum
Journal:  Acta Derm Venereol       Date:  2020-01-07       Impact factor: 3.875

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.